Clinical Trials Browser

Phase 2 × Mastocytosis, Cutaneous × Dermatologic × Clear all

NCT04846348 2024-04-25

Topical Composition Therapy for the Treatment of Cutaneous Mastocytosis

Phase 2 Terminated

1 enrolled 7 charts

DermatologicMyeloid

Mastocytosis, Cutaneous

NCT00457288 2007-11-12

Efficacy and Safety of TF002 in Cutaneous Mastocytosis

Phase 2 Completed

DermatologicMyeloid

Mastocytosis, Cutaneous